SYCP2 is differentially expressed in 11 cancers and shows much stronger RNA‐Seq signals in breast and cervical cancer as compared to normal controls, which is coherent with the GeneChip data (Figs 5E and S3E). This evidence concerns the gene SYCP2 and cervical cancer.